Wolf Group Capital Advisors Abb Vie Inc. Transaction History

Wolf Group Capital Advisors

$234 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $188,282 - $216,835	-1,302 Reduced 9.94%	11,795 $1.88 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $213,550 - $256,103	-1,544 Reduced 10.55%	13,097 $2.12 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $2,684 - $3,078	-20 Reduced 0.14%	14,641 $1.97 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $163,767 - $208,202	-1,190 Reduced 7.51%	14,661 $2.25 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $4.44 Million - $5.51 Million	-33,653 Reduced 67.98%	15,851 $2.57 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $3.53 Million - $4.46 Million	32,825 Added 196.8%	49,504 $6.7 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $34,580 - $39,253	-325 Reduced 1.91%	16,679 $1.8 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $77,434 - $86,266	736 Added 4.52%	17,004 $1.92 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $83,067 - $91,447	812 Added 5.25%	16,268 $1.76 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $15,132 - $20,429	188 Added 1.23%	15,456 $1.66 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $6,615 - $7,763	-77 Reduced 0.5%	15,268 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $15,554 - $20,814	212 Added 1.4%	15,345 $1.51 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $1,419 - $2,151	22 Added 0.15%	15,133 $1.15 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $8,150 - $10,198	-113 Reduced 0.74%	15,111 $1.34 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $34,135 - $41,040	542 Added 3.69%	15,224 $1.15 Million
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $71,284 - $91,118	-1,085 Reduced 6.88%	14,682 $1.07 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $7,559 - $8,897	-98 Reduced 0.62%	15,767 $1.27 Million
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $1.24 Million - $1.52 Million	15,865 New	15,865 $1.46 Million
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $1.53 Million - $1.7 Million	-17,239 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$89.78 - $106.23 $1.55 Million - $1.83 Million	17,239 New	17,239 $1.6 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $1.17 Million - $1.57 Million	-12,761 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $148,042 - $162,341	1,653 Added 14.88%	12,761 $1.23 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $775,893 - $991,055	11,108	11,108 $1.01 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.

Account